EW R&D to Revenue
Edwards Lifesciences · R&D to Revenue
EW R&D to Revenue
Latest reported17.79%period ending
EW FY R&D/Revenue (6.08% → 17.79%)
Latest values, visible window
High-resolution chart · PNG
EW r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 17.7863% | |
| 19.3584% | |
| 19.2196% | |
| 17.5609% | |
| 17.2594% | |
| 17.3426% | |
| 17.3114% | |
| 16.7132% | |
| 16.0859% | |
| 14.9205% | |
| 15.3627% | |
| 14.9167% | |
| 15.7908% | |
| 15.3348% | |
| 14.6729% | |
| 14.1258% | |
| 13.2814% | |
| 11.2467% | |
| 11.2089% | |
| 11.0125% | |
| 9.9208% | |
| 9.3398% | |
| 8.4602% | |
| 9.2614% | |
| 7.948% | |
| 6.8408% | |
| 6.0773% |